tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Narumi Nakagiri, 3 are a BUY (37.5%), 5 are a HOLD (62.5%).
Analyst Narumi Nakagiri, currently employed at DAIWA, carries an average stock price target met ratio of 55.56% that have a potential upside of 6.71% achieved within 61 days.
Narumi Nakagiri’s has documented 13 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PFE, Pfizer at 06-Aug-2024.
Analyst best performing recommendations are on AMGN (AMGEN).
The best stock recommendation documented was for AMGN (AMGEN) at 9/24/2021. The price target of $220 was fulfilled within 108 days with a profit of $16.45 (8.08%) receiving and performance score of 0.75.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$280
$14.14 (5.32%)
$235
4 days ago
(07-May-2025)
16/21 (76.19%)
$4.16 (1.51%)
430
Buy
$320
$54.14 (20.36%)
$324
9 days ago
(02-May-2025)
12/16 (75%)
$38.78 (13.79%)
75
Hold
$330
$64.14 (24.13%)
$303
1 months 2 days ago
(09-Apr-2025)
13/14 (92.86%)
$38.91 (13.37%)
730
Sell
$294
$28.14 (10.58%)
$275
2 months 6 days ago
(04-Mar-2025)
4/5 (80%)
$-18.19 (-5.83%)
89
Buy
$329
$63.14 (23.75%)
$310
3 months 1 days ago
(09-Feb-2025)
1/2 (50%)
$34.21 (11.60%)
54
What Year was the first public recommendation made by Narumi Nakagiri?
